NAME
ASCOTODIN 3 MG / ML + 1 MG / ML EYE DROPS, SOLUTION
PHARMACOTHERAPEUTIC CATEGORY
Ophthalmological products, artificial tears and other indifferent preparations.
ACTIVE PRINCIPLES
100 ml of solution contain: N-methylbenzoquinoline methylsulfate 0.300 g, tonzylamine hydrochloride 0.100 g.
EXCIPIENTS
Sodium chloride, sodium borate, carboxymethylcellulose, p-oxybenzoic esters, purified water.
INDICATIONS
Prevents professional and occasional irritation and photophthalmic lesions. Therefore, its use is indicated for all those (brazers, sportsmen, etc.) who are subjected to prolonged exposure to ultraviolet rays and very intense lights. It decreases the irritation phenomena of light diffraction in contact lens wearers. It is indicated as a curative in all affections in which the symptom dominates photophobia, actinic, electrical ophthalmias, keratitis, iritis.
CONTRAINDICATIONS / SECONDARY EFFECT
Hypersensitivity 'to the active ingredients or to any of the excipients. Children under the age of three. People with narrow-angle glaucoma and other serious eye diseases. Patients on antidepressant drug therapy.
DOSAGE
Instill a drop twice, five minutes apart, before exposure to too bright lights (ultra-violet rays, intense sun, strong artificial lights). Repeat the instillation after about three hours if exposure continues. For contact lens wearers a drop three times a day. In case of strong photophobia, instillation can be practiced even every two hours.
STORAGE
Store at a temperature not exceeding 30 degrees C, protected from light.
WARNINGS
If symptoms persist or worsen after a short period of treatment, consult your doctor; in any case, the product must not be used for more than 7 consecutive days, given the possibility that, otherwise, undesirable effects, even of a certain severity, may occur. Infections, pus, foreign bodies in the eye, mechanical, chemical, heat damage require the attention of the doctor. Although the product has poor systemic absorption, it should be used with caution in patients suffering from hypertension, hyperthyroidism, cardiac disorders and hyperglycemia (diabetes) and in subjects undergoing treatment with antidepressant drugs. The drug, if accidentally ingested or if used for a long period in excessive doses, can cause toxic phenomena. The medicine should be kept out of sight and reach of children as accidental ingestion can cause deep sedation. This medicinal product contains para-oxybenzoic esters which may cause allergic reactions (including delayed). The eye drops should not be used in children younger 'less than three years.
INTERACTIONS
No particular interactions or incompatibilities with other medicines for ophthalmic use are known. Do not use simultaneously with antidepressant drug therapy.
SIDE EFFECTS
The use of the drug can sometimes cause pupillary dilation, systemic absorption effects (hypertension, heart disease, hyperglycemia), increased intraocular pressure, nausea, headache. Sensitization phenomena may rarely occur. In this case it is necessary to interrupt the treatment and consult the doctor so that, if necessary, suitable therapy can be instituted. Report any suspected adverse reactions via the national reporting system.
PREGNANCY AND BREASTFEEDING
There are no known contraindications.